技术方法
ENGLISH ABSTRACT
Sabin株脊髓灰质炎灭活疫苗(Vero细胞)病毒灭活验证方法的建立及验证
申瑷琳
金玉翠
罗敏
李季
陈思
丁斐
唐微
潘俊杰
潘恺
王书畅
郭思远
罗志宇
施金荣
作者及单位信息
·
DOI: 10.3760/cma.j.cn311962-20240822-00057
Establishment and validation of virus inactivation validation method of Sabin strain inactivated poliovirus vaccine (Vero cell)
Shen Ailin
Jin Yucui
Luo Min
Li Ji
Chen Si
Ding Fei
Tang Wei
Pan Junjie
Pan Kai
Wang Shuchang
Guo Siyuan
Luo Zhiyu
Shi Jinrong
Authors Info & Affiliations
Shen Ailin
Quality Assurance Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Jin Yucui
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Luo Min
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Li Ji
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Chen Si
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Ding Fei
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Tang Wei
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Pan Junjie
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Pan Kai
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Wang Shuchang
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Guo Siyuan
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Luo Zhiyu
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
Shi Jinrong
Quality Control Department,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center for Combined Vaccines,Wuhan 430207,China
·
DOI: 10.3760/cma.j.cn311962-20240822-00057
20
10
0
0
0
0
PDF下载
APP内阅读
摘要

目的建立Sabin株脊髓灰质炎灭活疫苗(Vero细胞)病毒灭活验证方法,并进行方法学验证。

方法将Ⅰ、Ⅱ、Ⅲ型脊髓灰质炎病毒进行系列梯度稀释,分别接种于Vero细胞,进行2次盲传扩增,观察细胞病变情况。对该方法的最低检测限及细胞对病毒的敏感度进行摸索,并对该方法的精密度(重复性和中间精密度)和适用性进行验证。

结果建立的病毒灭活验证方法对Ⅰ、Ⅱ、Ⅲ型脊髓灰质炎病毒的检测限分别为-2、-1、0 lgCCID 50/mL。Ⅰ、Ⅱ、Ⅲ型脊髓灰质炎病毒对Vero细胞的最小接种浓度均为2 lgCCID 50/mL,在第7天均可观察到Vero细胞病变,即该细胞的敏感度为2 lgCCID 50/mL。同一检验人员重复检测同一批样品6次结果一致;2名检验人员在不同时间重复检测同一批样品6次结果一致;样品在-70 ℃及以下存放7 d与未冻存的样品检验结果一致;分别对生产过程中产生的Sabin株脊髓灰质炎灭活疫苗(Vero细胞)Ⅰ、Ⅱ、Ⅲ型单价灭活病毒液及原液各3批进行病毒灭活验证,取样当天和在-70 ℃及以下存放7 d后检验的样品的灭活验证检验结果一致,表明该方法的精密度和适用性均较好。

结论Sabin株脊髓灰质炎灭活疫苗(Vero细胞)病毒灭活验证方法能有效检测样品的灭活状态,可用于对病毒灭活效果的评价及工艺过程中对中间品等关键步骤的监控。

病毒灭活;验证;检测限;细胞敏感度;精密度;应用性
ABSTRACT

ObjectiveTo establish and verify the verification method of virus inactivation of Sabin strain inactivated poliovirus vaccine (Vero cell)(sIPV).

MethodsPoliovirus types Ⅰ, Ⅱ and Ⅲ were inoculated into Vero cells by a series of gradient dilution, and then amplified by blind cell passage twice. The cytopathic changes were observed, the minimum detection limit of this method and cell sensitivity to virus were explored, and the precision (repeatability and intermediate precision) and applicability of this method were verified.

ResultThe detection limits of the established virus inactivation validation method for poliovirus types Ⅰ, Ⅱ and Ⅲ were -2, -1 and 0 lgCCID 50/mL, respectively. The minimum inoculation concentration of poliovirus types Ⅰ, Ⅱ and Ⅲ to Vero cells was 2 lgCCID 50/mL, and the Vero cell lesions were all observed on day 7 .Thus, the sensitivity of the cell was 2 lgCCID 50/mL. The same inspector repeatedly tested the same batch of samples 6 times, and the test results were consistent. The same batch of samples were tested 6 times by different inspectors at different time, and the test results were consistent. The result of sample stored at -70 °C or below for 7 d was consistent with that of unfrozen sample.The inactivation verification test was carried out on 3 batches of types Ⅰ, Ⅱ and Ⅲ monovalent inactivated virus solution and bulk from sIPV production process, and the inactivation verification test results of the samples tested on the day of sampling and after 7 d of storage at -70 °C or below were consistent, indicating that the precision and applicability of the method were good.

ConclusionThe sIPV virus inactivation validation method effectively detects the inactivation status of the sample, which can be used to evaluate the virus inactivation effect and monitor key steps such as intermediates in the process.

Virus inactivation;Validation;Detectability;Cell sensitivity;Precision;Applicability
Shi Jinrong, Email: mocdef.qabq479022064

Shen Ailin and Jin Yucui contributed equally to the article

引用本文

申瑷琳,金玉翠,罗敏,等. Sabin株脊髓灰质炎灭活疫苗(Vero细胞)病毒灭活验证方法的建立及验证[J]. 国际生物制品学杂志,2025,48(01):50-54.

DOI:10.3760/cma.j.cn311962-20240822-00057

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
脊髓灰质炎(脊灰)是由脊灰病毒(poliovirus,PV)引起的急性传染病,主要侵犯脊髓前角运动神经元,多发于儿童 1。在过去的30年里,口服脊灰减毒活疫苗和脊灰灭活疫苗(inactivated poliovirus vaccine,IPV)的广泛应用显著降低了麻痹性脊灰的发病率。在极少数情况下,口服脊灰减毒活疫苗在疫苗接种者体内复制时可能会恢复神经毒性,从而引发疫苗相关性麻痹性脊灰 2。而IPV是灭活疫苗,可以极大程度减少疫苗相关性麻痹性脊灰的发生 3。在IPV的生产过程中,保证疫苗安全性的关键是PV的灭活过程 4。病毒灭活验证是在病毒灭活结束后检查样品中有无残余感染性病毒,以防止灭活过程中因各种因素导致病毒灭活不彻底而产生的安全隐患 5 , 6。目前,病毒灭活验证采用的经典方法是细胞盲传法 7,本研究拟建立有效且准确的PV灭活验证方法,用于疫苗生产过程中灭活工艺的控制。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
赵恒蔡秋龙袁梅. Sabin株脊髓灰质炎病毒经透析处理后病毒回收效果评价[J]. 中国生物制品学杂志 2018314):413-416. DOI: 10.13200/j.cnki.cjb.002154 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Wilton T Dunn G Eastwood D et al. Effect of formaldehyde inactivation on poliovirus[J]. J Virol 20148820):11955-11964. DOI: 10.1128/JVI.01809-14 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
吴雅楠廖国阳. 脊髓灰质炎病毒及其疫苗研究现状[J]. 中国生物制品学杂志 2020333):343-345,351. DOI: 10.13200/j.cnki.cjb.003019 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
赵恒李娅娴史磊. 生产过程中Sabin株脊髓灰质炎灭活疫苗的灭活效果验证[J]. 中国生物制品学杂志 2021346):643-646. DOI: 10.13200/j.cnki.cjb.003351 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
王憬惺. 病毒灭活确证实验和结果评价[J]. 中国输血杂志 199692):107-109. DOI: 10.13303/j.cjbt.issn.1004-549x.1996.02.034 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
洪小栩苏文全陶文健. 人用狂犬病疫苗病毒灭活验证试验方法修订的建议[J]. 中国药品标准 2009103):166-168. DOI: 10.19778/j.chp.2009.03.002 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
刘贺费春楠. 病毒灭活效果验证相关指示病毒研究进展[J]. 中国消毒学杂志 2018352):142-145. DOI: 10.11726/j.issn.1001-7658.2018.02.019 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
世界卫生组织. WHO全球行动计划—最大程度降低脊灰病毒相关设施风险(GAPⅢ)[R]. 日内瓦世界卫生组织 2014.
返回引文位置Google Scholar
百度学术
万方数据
[9]
Paul AO . The cutter incident:how America’s first polio vaccine led to the growing vaccine crisis[J]. J R Soc Med 2006993):156.
返回引文位置Google Scholar
百度学术
万方数据
[10]
王晶晶廖芸王丽春. EV71灭活疫苗(人二倍体细胞)灭活工艺验证[J]. 中国生物制品学杂志 20152810):1063-1066,1071. DOI: 10.13200/j.cnki.cjb.001090 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
国家药典委员会. 中华人民共和国药典2020年版三部[M]. 北京中国医药科技出版社 2020201-203.
备注信息
A
施金荣,Email: mocdef.qabq479022064
B

申瑷琳、金玉翠:实验设计、研究实施、数据采集、数据分析、论文撰写;罗敏、施金荣:实验设计、技术支持、支持性贡献;李季、陈思、丁斐、唐微、潘俊杰、潘恺、王书畅、郭思远:研究实施、数据采集;罗志宇:研究实施、支持性贡献

C

申瑷琳和金玉翠对本文有同等贡献

D
所有作者均声明不存在利益冲突
E
湖北省重点研发计划 (2023BCB028)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号